Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis.

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Abstract Text:

R Condos,N W Schluger,

The most disturbing aspect of the current epidemic of tuberculosis (TB) is the appearance of large numbers of strains of Mycobacterium tuberculosis that are resistant to one or more of the first-line agents used to treat the disease. Mortality associated with a multidrug-resistant strain of tuberculosis (MDR-TB) infection is reported to be extremely high, in many cases no different from the mortality of tuberculosis in the pre-antibiotic era. Infection control measures have limited the spread of MDR-TB. However, many outbreaks over the last several years have created a large reservoir of MDR-TB infection. In order to treat the cases of MDR-TB that are occurring now and which will undoubtedly occur in the future, new approaches to treatment will be needed. Recent research into the immunopathogenesis of tuberculosis has provided insight into the important constituents of the host immune system needed to control the infection in vivo. These elements include CD4+ and CD8+ T cells as well as cytokines such as interferon gamma (IFNgamma), interleukin-12 (IL-12), and tumour necrosis factor (TNF). IL-2, IFNgamma and M. vaccae vaccination have all shown promising effects in small preliminary studies. Evidence suggests that TNF antagonists and IL-12 may also prove useful in the treatment of drug-susceptible TB and MDR-TB. Further studies are needed to determine the precise role of these recombinant proteins in the treatment of TB.

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Publishing Authors By Initials

R Condos,NW Schluger,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: BioDrugs : clinical immunotherapeutics, biopharmac

VOLUME: 11

Page Numbers: 165-73

Journal Abbreviation:

ISSN: 1173-8804

DAY: 22

MONTH: Mar

YEAR: 1999

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9705305

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis.

AFFILIATION: The Bellevue Chest Service and The Division of Pulmonary and Critical Care, Medicine, New York, USA.

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BioDrugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis Related Publications

• Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis.
• Necrotizing ulcerative gingivitis in the Army; incidence, communicability and treatment.
• Osseous resection; a basic principle in periodontal surgery.
• Periodontics today: dentistry tomorrow.
• Suppose they gave an epidemic and nobody came?
• The epidemiology of tuberculosis in the United States.
• Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?
• Tuberculosis.
• Underreported threat of multidrug-resistant tuberculosis in Africa.
• Use of an Interferon-{gamma} Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients.